-
Most Recent
Healthcare Stocks
Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.
7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.
7 Dependable Dividend Stocks for Long-Term Income
Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.
3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct
These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.
Other industries you might be interested in
Recent Healthcare Stocks Articles
Affordable Care Act Turns 5: Healthcare Stocks Still Soaring
The fifth anniversary of the Affordable Care Act marks a half-decade of remarkable outperformance on the part of healthcare stocks.
Are Large-Cap Biotech Stocks in a Bubble?
Biotech stocks have outpaced the rest of the market by a huge margin, but it takes more than gaudy performance numbers to create a bubble.
Valeant Shareholders May Lose in the Salix ‘Win’ (VRX, SLXP, ENDP)
Valeant Pharmaceuticals (VRX) swiped Salix Pharmaceuticals (SLXP) from Endo International (ENDP), but was it really worth it?
MARCH MADNESS: Amgen (AMGN) vs. CVS Health (CVS)
Amgen (AMGN) and CVS Health Corp (CVS) find themselves on opposite sides when it comes to pricing for the latest drugs.
Trade of the Day: Merck (MRK)
With major U.S. stock indexes returning to bullish trends, today's trade is a call option in "Big Pharma" stock Merck (MRK).
This Particular Stock Bubble Is Bound to Burst in 2015
Healthcare stocks may have been all the rage in 2014, but time, hubris and exuberance have finally caught up with the sector.
Gilead Stock: This Beatdown Was Way Overdone (GILD)
Gilead Sciences, Inc. (GILD) was driven down by news from AbbVie, but the market may have overreacted and turned Gilead stock into a value buy.
2 New Funds Add a New Twist to Biotech Stocks
Calling all fans and followers of breakthrough biotech stocks! Stop searching for the next big winner and just own one of these new biotech ETFs instead.
Biogen: BIIB Stock Is Ready to Play Catchup
Biogen's promising results of its Alzheimer's drug sent BIIB stock rallying. Traders now have a clear line in the sand to buy the stock.
Trade of the Day: Gilead Sciences (GILD)
All signals point to a bullish trend, and as we dive back into the market after taking a pause, I’ve noticed that the health care sector is gaining momentum. Today, I’d like to look into a biotech position that has great growth potential.
Humana: Prognosis for Healthy Growth
Humana is a giant, well-integrated health insurance company that will profit from strategic investment combined with Obamacare’s expansion of insurance rolls. Regardless of political or economic vicissitudes, the company is poised for long term growth.
Walgreen: Tech-Savvy Investments Mean Major Upside for WAG Stock
Walgreen, through its partnership with lab test innovator Theranos, could change healthcare forever. That deal alone could mean huge upside for the stock.
Here’s What to Expect From Australian Biotechs
Australian science is strong and a leader in the biotech space. Here's why investors should look to Australia for biotech stocks to buy.
